[CERT] ASTRAZENECA PLC Certification Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

CERT

Rhea-AI Filing Summary

Analyzing...

03/04/2026 - 09:14 AM

CERT - ASTRAZENECA PLC

CERT Filing - ASTRAZENECA PLC

This filing is available as a PDF document.

Filing Type: CERT

Company: ASTRAZENECA PLC (AZN)

Acceptance Date: 2026-03-04T09:14:26.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

AstraZeneca

NYSE:AZN

AZN Rankings

#36 Ranked by Market Cap

N/A Ranked by Dividends

AZN Latest News

Feb 20, 2026

CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting

Feb 19, 2026

ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer

Feb 13, 2026

Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine

Feb 11, 2026

AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US

Feb 10, 2026

AstraZeneca results: FY and Q4 2025

AZN Latest SEC Filings

Mar 2, 2026

[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)

Mar 2, 2026

[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)

Feb 26, 2026

[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)

Feb 25, 2026

[424B2] ASTRAZENECA PLC Prospectus Supplement

Feb 25, 2026

[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)

AZN Stock Data

Market Cap 312.88B

Float 1.50B

Industry Drug Manufacturers - General

Sector Healthcare

Website Link

Country United Kingdom

City Cambridge